Clinical Trial Update: Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated panitumumab with chemotherapy in patients with advanced colorectal cancer after bevacizumab treatment; the study is completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Mucinous Adenocarcinoma of the Colon
• Mucinous Adenocarcinoma of the Rectum
• Rectal Cancer
• Signet Ring Adenocarcinoma of the Colon
• Signet Ring Adenocarcinoma of the Rectum

Drugs mentioned

• Chemotherapy (chemotherapy)
• Panitumumab (panitumumab)

Snippet

Sponsor: John Hays | Conditions: Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum | Phase 2 | Status: COMPLETED | Results posted: 2025-02-05